tobramycin 75 MG/ML Inhalation Solution [Bethkis]

Verify with CMS →

tobramycin

RxCUI: 1314768

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.
1.5%
Plan Coverage
75
Plans Covering
T3
Avg Tier
100%
Prior Auth Required

What the CMS Formulary Data Shows for tobramycin 75 MG/ML Inhalation Solution [Bethkis]

Per the CMS 2026 Part D formulary file, tobramycin 75 MG/ML Inhalation Solution [Bethkis] (RxNorm concept RXCUI 1314768, generic name tobramycin) appears on 2 distinct formulary files spanning 75 Medicare Part D plan offerings - 1.5% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 3.

Real-world access to tobramycin 75 MG/ML Inhalation Solution [Bethkis] depends on utilization management as much as tier placement: 100% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 195,319 Part D beneficiaries filled tobramycin 75 MG/ML Inhalation Solution [Bethkis] in 2023, with total plan-and-beneficiary spending of $2,165,446 and an average per-beneficiary annual cost of $11.09. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry tobramycin 75 MG/ML Inhalation Solution [Bethkis] today.

Coverage Details

Formularies covering
2
Plans covering
75
Coverage rate
1.5%
Tier range
Tier 1 – Tier 5
Average tier
Tier 3, Preferred Brand

Restrictions

Prior authorization required
100% of formularies
Step therapy required
0% of formularies
Quantity limits
0% of formularies

2023 Medicare Spending

Beneficiaries
195,319
Total spending
$2,165,446
Avg per beneficiary
$11.09

Tier Distribution Across Plans

1 plans
Tier 1, Preferred Generic
74 plans
Tier 5, Specialty

Medicare Advantage Plans (MA-PD) Covering tobramycin 75 MG/ML Inhalation Solution [Bethkis]

75 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
Horizon NJ TotalCare (HMO D-SNP) HORIZON HEALTHCARE OF NEW JERSEY, INC. T1 Yes $0 NJ
SCAN Connections (HMO D-SNP) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Connections at Home (HMO D-SNP) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Classic (HMO) SCAN HEALTH PLAN NEVADA, INC. T5 Yes $0 NV
SCAN Balance (HMO C-SNP) SCAN HEALTH PLAN NEVADA, INC. T5 Yes $0 NV
SCAN Strive (HMO C-SNP) SCAN HEALTH PLAN NEVADA, INC. T5 Yes $0 NV
SCAN MyChoice (HMO) SCAN HEALTH PLAN NEVADA, INC. T5 Yes $0 NV
SCAN Classic (HMO) SCAN DESERT HEALTH PLAN, INC. T5 Yes $0 AZ
SCAN Balance (HMO C-SNP) SCAN DESERT HEALTH PLAN, INC. T5 Yes $0 AZ
SCAN Embrace (HMO-POS I-SNP) SCAN DESERT HEALTH PLAN, INC. T5 Yes $0 AZ
SCAN Strive (HMO C-SNP) SCAN DESERT HEALTH PLAN, INC. T5 Yes $0 AZ
SCAN MyChoice (HMO) SCAN DESERT HEALTH PLAN, INC. T5 Yes $0 AZ
SCAN Classic WA (HMO) SCAN HEALTH PLAN (WA) T5 Yes $0 WA
SCAN MyChoice WA (HMO) SCAN HEALTH PLAN (WA) T5 Yes $0 WA
SCAN Classic (HMO) SCAN HEALTH PLAN (NM) T5 Yes $0 NM
SCAN Balance (HMO C-SNP) SCAN HEALTH PLAN (NM) T5 Yes $0 NM
SCAN Strive (HMO C-SNP) SCAN HEALTH PLAN (NM) T5 Yes $0 NM
SCAN MyChoice (HMO) SCAN HEALTH PLAN (NM) T5 Yes $0 NM
SCAN Classic (HMO) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Classic (HMO) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Classic (HMO) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Classic (HMO) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Classic (HMO) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Classic (HMO) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Classic (HMO) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Balance (HMO C-SNP) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Prime (HMO) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Classic (HMO) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Balance (HMO C-SNP) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Classic (HMO) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Balance (HMO C-SNP) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Alta (HMO) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Venture (HMO) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Venture (HMO) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Embrace (HMO I-SNP) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Embrace (HMO I-SNP) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Embrace (HMO-POS I-SNP) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Affirm partnered with Included LGBTQ+ Health (HMO) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Affirm partnered with Included LGBTQ+ Health (HMO) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Strive (HMO C-SNP) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Strive (HMO C-SNP) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Inspired by women for women (HMO) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Classic (HMO) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Balance (HMO C-SNP) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Balance (HMO C-SNP) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Balance (HMO C-SNP) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Balance (HMO C-SNP) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN Affirm partnered with Included LGBTQ+ Health (HMO) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN MyChoice (HMO) SCAN HEALTH PLAN T5 Yes $0 CA
SCAN MyChoice (HMO) SCAN HEALTH PLAN T5 Yes $0 CA

Frequently Asked Questions

Is tobramycin 75 MG/ML Inhalation Solution [Bethkis] covered by Medicare Part D?

Yes, tobramycin 75 MG/ML Inhalation Solution [Bethkis] is covered by 75 Medicare Part D plans (1.5% of all Part D formularies).

What tier is tobramycin 75 MG/ML Inhalation Solution [Bethkis] on Medicare Part D plans?

tobramycin 75 MG/ML Inhalation Solution [Bethkis] averages Tier 3 across Part D plans, ranging from Tier 1 to Tier 5.

Does tobramycin 75 MG/ML Inhalation Solution [Bethkis] require prior authorization?

100% of Part D formularies require prior authorization for tobramycin 75 MG/ML Inhalation Solution [Bethkis]. Step therapy: 0%. Quantity limits: 0%.

How much does Medicare spend on tobramycin 75 MG/ML Inhalation Solution [Bethkis]?

In 2023, total Medicare Part D spending on tobramycin 75 MG/ML Inhalation Solution [Bethkis] was $2,165,446, covering 195,319 beneficiaries. The average spend per beneficiary was $11.09.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare Editorial